TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Microbiotech/se AB
Closing information (x1000 SEK)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
3,107
|
2,659
|
3,195 |
| Financial expenses |
0
|
1
|
0 |
| Earnings before taxes |
247
|
22
|
-62 |
| EBITDA |
236
|
23
|
-62 |
| Total assets |
2,288
|
2,242
|
2,535 |
| Current assets |
2,288
|
2,242
|
2,535 |
| Current liabilities |
269
|
399
|
691 |
| Equity capital |
1,938
|
1,747
|
1,732 |
| - share capital |
330
|
330
|
330 |
| Employees (average) |
4
|
3
|
4 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
84.7%
|
77.9%
|
68.3% |
| Turnover per employee |
777
|
886
|
799 |
| Profit as a percentage of turnover |
7.9%
|
0.8%
|
-1.9% |
| Return on assets (ROA) |
10.8%
|
1.0%
|
-2.4% |
| Current ratio |
850.6%
|
561.9%
|
366.9% |
| Return on equity (ROE) |
12.7%
|
1.3%
|
-3.6% |
| Change turnover |
448
|
-536
|
655 |
| Change turnover % |
17%
|
-17%
|
26% |
| Chg. No. of employees |
1
|
-1
|
4 |
| Chg. No. of employees % |
33%
|
-25% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.